CDH1 and urothelial carcinoma: Decrease in E-cadherin expression is noted in poorly differentiated urothelial carcinoma [13], and a loss of expression is a feature of the plasmacytoid variant of urothelial carcinoma, which is similar to ILC and expresses GATA3 [5].